Vanberra Signal

Calypso Medical Technologies

Curated by Signal

Real-time localization technology for Oncology and radiation therapy

Overview

Real-time localization technology for Oncology and radiation therapy. The Calypso System features GPS for the Body technology and Beacon electromagnetic transponders that together currently provide a solution to continuously and accurately track target location to improve the precision of prostate cancer treatments. The transponders are implanted into the prostate or prostatic bed and then tracked with the 4D localization and tracking system so that beams can be precisely delivered to targeted tumors during radiotherapy and radiosurgery.

Key facts

Founded
2000

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Provider of genetic tests for prenatal and cancer detection

    Life Sciences TechnologyNew York City, United States
  • Provider of hypersensitive pathogen detection kits and platform for the IVD industry

    Life Sciences TechnologySanta Clara, United States
  • Developer of a wearable non-invasive neuromodulation device

    Life Sciences TechnologyStanford, United States

About Calypso Medical Technologies

What does Calypso Medical Technologies do?

Real-time localization technology for Oncology and radiation therapy.

Where is Calypso Medical Technologies headquartered?

Calypso Medical Technologies is headquartered in Seattle, United States.

When was Calypso Medical Technologies founded?

Calypso Medical Technologies was founded in 2000.

Which sector is Calypso Medical Technologies in?

Calypso Medical Technologies operates in Life Sciences Technology.

Who are Calypso Medical Technologies's competitors?

Companies similar to Calypso Medical Technologies include Companion Genomics, Medix Biotechnologies, and Cala Health.